Home › Mesothelioma › California › Los Angeles
Mesothelioma clinical trials in Los Angeles, CA
6 studies for Mesothelioma are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
SW-682 in Advanced Solid Tumors
RecruitingPhase 1
- USC Norris Comprehensive Cancer Center and Hospital, Los Angeles
TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
RecruitingPhase 1/2
- USC Norris Comprehensive Cancer Center, Los Angeles
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- University of California Los Angeles Medical Center, Los Angeles
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RecruitingPhase 1/2
- UCLA Medical Center, Los Angeles
A Study of VET3-TGI in Patients With Solid Tumors
RecruitingPhase 1
- USC/Norris Comprehensive Cancer Center, Los Angeles
A Study of NX-1607 in Adults With Advanced Malignancies
RecruitingPhase 1
- University of Southern California, Los Angeles
About Mesothelioma
Mesothelioma is a tumor of mesothelium, a tissue that lines lungs and other organs. Most people who get it have inhaled asbestos. Read the symptoms.
More about Mesothelioma on MedlinePlus
Mesothelioma trials in other cities
- Houston, TX15 studies
- New York City, NY10 studies
- Washington, DC9 studies
- Chicago, IL9 studies
- Boston, MA8 studies
- Nashville, TN8 studies
- Arlington, VA6 studies
- Pittsburgh, PA6 studies
- Philadelphia, PA6 studies
- Seattle, WA6 studies
- Edison, NJ5 studies
- Columbus, OH5 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.